JS Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

JS Capital Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-21,500	Closed	-$3.26M	–	171
2020 Q4	$3.26M	Buy	21,500 +15,600	+264%	+$2.23M	0.16%	41
2020 Q3	$799K	Sell	5,900 -10,300	-64%	-$1.4M	0.04%	50
2020 Q2	$2.21M	Buy	+16,200	New	+$2.07M	0.17%	31
2020 Q1	–	Sell	-68,600	Closed	-$8.27M	–	159
2019 Q4	$8.27M	Buy	68,600 +61,479	+863%	+$6.86M	0.95%	24
2019 Q3	$709K	Buy	7,121 +3,221	+83%	+$337K	0.1%	35
2019 Q2	$425K	Sell	3,900 -2,100	-35%	-$223K	0.06%	25
2019 Q1	$671K	Sell	6,000 -9,800	-62%	-$1.07M	0.14%	28
2018 Q4	$1.52M	Buy	15,800 +3,300	+26%	+$350K	0.43%	22
2018 Q3	$1.52M	Buy	+12,500	New	+$1.47M	0.42%	24

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

JS Capital Management's IBB Position: Q1 2021 in Review

JS Capital Management sold out of iShares Biotechnology ETF (IBB) in Q1 2021, closing a stake of 21,500 shares — an estimated $3.26M sold.

JS Capital Management first reported a position in IBB in Q3 2018 and held it in 9 quarters. The position peaked at $8.27M in Q4 2019. 845 funds tracked by Wall St. Rank hold IBB as of Q1 2021.

JS Capital Management reported no remaining iShares Biotechnology ETF position as of Q1 2021 after selling out during the quarter.
JS Capital Management sold 21,500 iShares Biotechnology ETF shares in Q1 2021, an estimated $3.26M.
JS Capital Management first reported a position in iShares Biotechnology ETF in Q3 2018 and held it in 9 quarters.
JS Capital Management's iShares Biotechnology ETF position peaked at $8.27M in Q4 2019.
845 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2021.

Based on JS Capital Management's 13F filing for Q1 2021, filed 17 May 2021.